Long-term management of patients with urea cycle disorders
- PMID: 11148550
- DOI: 10.1067/mpd.2001.111837
Long-term management of patients with urea cycle disorders
Abstract
The long-term treatment of patients with urea cycle disorders (UCDs) includes diet treatment and use of specific medications. Guidelines are provided for patients with a severe phenotype. However, treatment must be tailored for each individual, especially with regard to residual enzyme function and in vivo metabolic capacity. This will be reflected in tests used for monitoring therapy that should be performed on a periodic basis. The goal of therapy is to eliminate chronic complications, a laudable but rarely attainable goal. Sick-day rules are discussed. Chronic management also includes diverse services that are essential to the success of the metabolic program. These include neurologic and developmental evaluations, feeding team evaluation and therapy, physical and occupational therapies, speech therapy, school and educational services, social service intervention, psychologic services, and genetic counseling.
Similar articles
-
Proceedings of a satellite meeting on advances in inherited urea cycle disorders. Vienna, 20-21 May 1997.J Inherit Metab Dis. 1998;21 Suppl 1:1-159. J Inherit Metab Dis. 1998. PMID: 9686340 No abstract available.
-
Management of heritable disorders of the urea cycle and of Refsum's and Fabry's diseases.Prog Clin Biol Res. 1979;34:183-200. Prog Clin Biol Res. 1979. PMID: 93755 No abstract available.
-
Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.J Clin Invest. 1984 Dec;74(6):2144-8. doi: 10.1172/JCI111640. J Clin Invest. 1984. PMID: 6511918 Free PMC article.
-
Alternative pathway therapy for urea cycle disorders.J Inherit Metab Dis. 1998;21 Suppl 1:101-11. doi: 10.1023/a:1005365825875. J Inherit Metab Dis. 1998. PMID: 9686348 Review.
-
[Urea cycle disorders].Ryoikibetsu Shokogun Shirizu. 1995;(8):367-9. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8581654 Review. Japanese. No abstract available.
Cited by
-
[Patients with ornithine transcarbamylase deficiency. Anaesthesiological and intensive care management].Anaesthesist. 2005 Dec;54(12):1201-8. doi: 10.1007/s00101-005-0911-5. Anaesthesist. 2005. PMID: 16136341 German.
-
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):439-448. doi: 10.1080/17425255.2017.1262843. Epub 2016 Nov 28. Expert Opin Drug Metab Toxicol. 2017. PMID: 27860485 Free PMC article. Review.
-
Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: patient perspectives.Patient Prefer Adherence. 2017 Sep 6;11:1489-1496. doi: 10.2147/PPA.S136754. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28919721 Free PMC article. Review.
-
Hyperammonemia in azotemic cats.J Feline Med Surg. 2021 Aug;23(8):700-707. doi: 10.1177/1098612X20972039. Epub 2020 Nov 20. J Feline Med Surg. 2021. PMID: 33215950 Free PMC article.
-
Drug treatment of inborn errors of metabolism: a systematic review.Arch Dis Child. 2013 Jun;98(6):454-61. doi: 10.1136/archdischild-2012-303131. Epub 2013 Mar 26. Arch Dis Child. 2013. PMID: 23532493 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical